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Abstract 
Medicated skin care products are available in various forms; ranging from lotions 
and creams to bandages and membranes. In this study, anti-bacterial particulate laden 
fibrous membranes were prepared via electrospraying of tetracycline hydrochloride 
(TE-HCL) loaded poly(ε-caprolactone) (PCL) particles alongside electrospinning of 
thermoplastic polyurethane (TPU) fibers, through which both mechanical and 
biological aspects of a complete membrane system can be achieved. Random (R) and 
ordered (P and V) patterns of TPU fibrous membranes (FMs) were afforded using a 
rotating collector. Water contact angle and bacterial inhibition zone tests were 
performed to assess suitability of the system specifically for wound care. Stress-strain 
and in-vitro drug release tests were performed to assess suitability of newly developed 
systems specifically for hybrid membranes (HMs). The highest tensile strength (32.1 ± 
4.9 MPa) with elasticity (104.2 ± 6.0 %) and the most sustained release rate indicate 
HMs (P) are potentially suitable materials for wound care applications. 
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1. Introduction 
Medical dressings have been widely used to promote healing of various wound 
types such as venous ulcers 1,2 and skin burns 3,4. Traditional medical dressing systems, 
including cottons, bandages and gauzes, generally provide only simplistic functions 5. 
In most cases these need to be used in conjunction with medicated creams or liquids to 
provide therapeutic benefits or accelerate wound healing. In view of this, various 
engineering methods have been used to develop novel medical dressings in the last two 
decades; each with specific advantages as well as a clear focus on the desired scope of 
application. For example, bandages possessing micro-porous structures have been 
prepared using freeze-drying and are favorable for exudate absorption from wound 
surfaces 6. In addition, electrospun membranes can effectively control release rate of 
loaded nitric oxide (NO) which is known to contribute towards improved wound 
healing 7. Several advances have also been made providing additional functionalities 
towards these systems such as wound monitoring 8 and enhanced anti-bacterial 
properties 9. Since the wound care market contributes to a very large proportion of 
pharmaceutical device sales and possesses huge development potential (forecast to 
reach $ 22.01 billion by 2022 10), there is ongoing development and newer conceptual 
designs in this area. 
Furthermore, developments in medical dressings prepared from polymer matrix 
composites containing active pharmaceutical ingredients (APIs) are on the increase 11-
16. In general, API is dispersed in a polymer matrix which forms the base of dressings 
and provides protection for wounds. Depending on the application, the matrix is 
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designed to provide rapid release of API for emergency conditions 13 or sustained 
release of API to achieve long-term management (e.g. of chronic wounds, such as leg 
ulcers 15 and deep burns 16). 
Electrospinning (ES) is a facile method to produce fibrous materials with pre-
determined physical and chemical properties by adjusting reaction and process 
parameters. Furthermore, electrospun materials have been explored in electronics, 
materials science and biomedicine due to facile structure engineering and related 
performance 17,18. In recent times, the engineering of advanced electrospun fibers with 
greater alignment, tailored surface morphology and compartmentalized internal 
structures has been shown. This has been achieved using several core and peripheral 
components including coaxial nozzles 19, side-by-side channels 20 and tip collectors 21. 
In addition, ES can be used to prepare stable and uniform composite materials with 
enhanced properties. For example, fillers with excellent thermal properties have been 
dispersed consistently in fibers through the ES technique to improve material properties 
of composites 22,23. 
Electrospraying (ESy) is another flexible electrohydrodynamic technique that has 
been used to produce micro- and nano-scaled particles 24,25. Applications involving 
active incorporated structures have shown improved cellular uptake 26, enhanced 
intestinal permeability 27, increased oral bioavailability 28 and several other advantages 
as drug delivery dosage forms 29. The ESy process is similar to ES but with differences 
to jet break-up and droplet elongation arising from physical properties of the liquid 
medium (or formulation) used 30. Previous studies have shown combinatorial 
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approaches; where both ES and ESy techniques have been used (simultaneously or one 
directly after the other) to achieve complex 3D structures. These include bead 
embedded nanofibers for scaffolds 31, nanoparticle-loaded polyimide matrices 32 and 
honeycomb-like fibrous materials 33. Furthermore, by utilizing physical and chemical 
properties of materials; resulting micron-scaled architectures provide timely 
developments for cell growth 31, capacitors 32 and tissue regeneration 34. 
Thermoplastic polyurethane (TPU) is a class of thermoplastic elastomer, which has 
been used to develop several composite biomaterials because of its excellent 
mechanical properties, biocompatibility and blood compatibility 35,36. Poly(ε-
caprolactone) (PCL) is a linear aliphatic biocompatible polyester, which has been 
widely used in the medical field for numerous applications, including pharmaceutical 
dosage form development 37,38 and cardiovascular stents 39,40. For drug delivery, PCL is 
often used as a matrix material to prolong active release 41-44. Moreover, when compared 
to other common biocompatible polymers, such as PLA, PCL has higher drug 
permeation 45, better patient compliant feel 46, enhanced degradation times 47 as well as 
economic factors. 
In this study, elastic anti-bacterial hybrid membranes (HMs) were prepared as 
novel wound healing composite materials using a combination of ES and ESy 
techniques. Three TPU fibrous membranes (FMs) were prepared as dressing support 
materials (providing elasticity) using a rotating collector. Tetracycline hydrochloride 
(TE-HCL) was loaded into PCL microparticles (MPs) as matrix based controlled release 
components. Optical microscopy (OM), scanning electron microscopy (SEM) and 
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Fourier Transform infrared (FTIR) spectroscopy were used to study morphology and 
chemical components of various HMs. The developed elastic anti-bacterial hybrid 
membranes show potential application in wound healing, since the hydrophilic inner 
layer is capable of absorbing exudate and keep the wound site clean, while hydrophobic 
outer layer provides waterproofing ability. In addition, mechanical properties and TE-
HCL antibiotic release can be controlled for long-term use and facilitate recovery at the 
wound site through geometrical fiber arrangement. Finally using fiber and particle 
laden system ensures the system provides breathability which would also expedite 
wound healing. 
 
2. Experimental Section 
2.1. Materials 
PCL (mean Mw = 4.5 × 104 g/mol) was purchased from Sigma-Aldrich Ltd., St 
Louis, USA. TPU (mean Mw = 2.0 × 104 g/mol) was provided by Solvay China Ltd., 
Shanghai, China. Glacial acetic acid (HAc, 99.5 %), N,N-Dimethylformamide (DMF, 
99.8 %) and Phosphate-buffered saline (PBS, pH = 7.4) were obtained from Sinopharm 
Chemical Reagent Co., Ltd., Shanghai, China. TE-HCL was supplied by Amresco Inc., 
USA. Ultrapure water was prepared using a Millipore Milli-Q Reference ultrapure 
water purifier (USA). All materials were of the analytical grade and used without 
further purification. 
Escherichia coli (E. coli) was purchased from Maojie Microbial Sci. & Tech. Co., 
Ltd., Nanjing, China. Staphylococcus aureus (S. aureus) was supplied by National 
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Center for Medical Culture Collections, Beijing, China. Violet Red Bile agar and Baird-
Parker agar were obtained from Hope Bio-Technogy Co., Ltd., Qingdao, China. 
 
2.2. Preparation of PCL and TPU solutions 
6 wt% PCL solution was prepared by dissolving PCL in HAc. TE-HCL was 
selected as a model antibiotic and was subsequently added to the PCL solution at 0.48 
wt%. 20 wt% TPU solution was prepared by dissolving the polymer in DMF. Each 
initial mixture was subjected to magnetic stirring (VELP ARE heating magnetic stirrer, 
Italy) continuously at 300 rpm for 4 h at the ambient temperature (25 °C) to ensure 
complete dissolution. 
 
2.3. Fabrication of hybrid membranes (HMs) 
Figure 1 shows experimental set-up which comprises high voltage power supply 
(Glassman high voltage Inc. series FC, USA), a syringe pump (KD Scientific KDS100, 
USA), a rotating drum and a stainless steel needle system. The needle (inner and outer 
diameters: 0.20 and 0.24 mm, respectively) was connected to the high voltage power 
supply and was positioned directly above the earth-grounded rotating drum (diameter 
and length 7 and 14 cm (respectively), rotation speed variable: 0-4000 rpm). The 
rotating drum was layered with Aluminum foil for ease of removal post deposition.  
In the first step, a TPU solution was infused from a plastic syringe into the needle 
inlet via the syringe pump. TPU fibers were fabricated using ES whilst maintaining a 
flow rate and an applied voltage at 0.5 mL/h and 12 kV, respectively. The distance 
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between needle outlet and rotating drum was set to 11 cm. The rotation speed of the 
collector was varied from 200 to 3200 rpm during this step for preparing TPU FMs with 
three well defined patterns. Samples were collected for 20 mins and subsequently 
analyzed using microscopy. TPU FMs consisting of random (TPU FMs (R)) and 
parallel fibers (TPU FMs (P)) were prepared at 200 rpm and 3200 rpm, respectively. 
TPU FMs consisting of vertical fibers (TPU FMs (V)) were prepared by repeating TPU 
FMs (P) fabrication step four times. At designated time intervals (5 mins) deposited 
TPU fibers were repositioned 90° clockwise every two times. An extended collection 
time (4 h) was used to prepare samples for coating membranes with PCL MPs in the 
next step. 
The second step was to load a PCL solution into a separate plastic syringe at a flow 
rate of 1.0 mL/h. The distance between needle outlet and rotating drum was maintained 
at 9 cm and an applied voltage was kept at 9 kV. PCL MPs were fabricated using ESy 
and the collection time was 3 h. The rotation speed was set at 200 rpm to ensure equal 
distribution over membranes. MPs were collected directly on to TPU FMs. The 
resulting HMs comprising both MPs and FMs were termed HMs (R), HMs (P) and HMs 
(V), respectively (Table 1). All experiments were performed at ambient temperature 
(25 °C). Finally, HMs were removed from the collector and dried in air at 12 h before 
characterization. 
 
2.4. Characterization 
Optical microscopy (OM, Phenix BMC503-ICCF, China) and scanning electron 
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microscopy (SEM, SU 8000 SEM, Hitachi, Japan) analyses were performed to study 
morphology of PCL MPs, TPU FMs and HMs. For SEM analysis, samples were 
observed at an accelerating voltage of 20 kV. Prior to analysis, samples were sputter-
coated (Ion Sputter MC 1000, Hitachi, Japan) with a thin layer of gold for 120 s at a 
current intensity of 25 mA. Fourier Transform infrared spectroscopy (FTIR, IR 
Affinity1, Shimadzu, Japan) was performed to determine the chemical composition of 
samples. Prior to analysis, samples were prepared by the KBr pellet method: 2 mg of 
each sample (pure PCL particles, pure TE-HCL powder, TE-HCL-loaded PCL MPs, 
TPU FMs and HMs) was mixed with 200 mg of KBr medium, and then the mixture was 
compressed into a pellet at 20 MPa for 120 s, respectively. Spectra were recorded from 
3500 to 500 cm-1 at a resolution of 4 cm-1. 
 
2.5. Water contact angle measurements  
An optical contact angle and interface tension meter (SL200KB, KINO Industry 
Co. Ltd., USA) was used to measure water contact angles for determining 
hydrophobic/hydrophilic nature of membrane surfaces. An ultrapure water droplet (~10 
µL) was dripped onto each sample, and then values of contact angle were calculated 
and recorded automatically. For each sample, measurements were taken in triplicate. 
 
2.6. Tensile test 
A universal materials tester (Zwick/Roell Z020, Zwick, Germany) was used to 
measure mechanical properties of HMs. Prior to analysis, 40 × 10 mm2 sized samples 
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were prepared. Assessment was initiated without preload and samples were extended 
with a 500 N load cell at a stretching speed of 10 mm/min. For HMs (P), the tensile test 
direction was along the fiber axis. For each sample type, measurements were taken in 
triplicate. 
 
2.7. In vitro drug release test 
Each sample constituting 200 mg HMs was placed into a glass vial with 10 mL 
PBS (pH = 7.4) as the release medium 43. TE-HCL release was investigated using UV 
spectrophotometry (Shimadzu, Japan) recorded from 200 to 800 nm over a 120 h test 
period at the ambient temperature (25 °C). At each designated time interval, 4 mL of 
supernatant was removed, and the vial was replenished with 4 mL of fresh PBS. An 
absorbance (wavelength = 365 nm) peak was selected to determine concentration of 
TE-HCL following calibration. For each sample type experiments were performed in 
triplicate. 
The quantity of encapsulated TE-HCL was calculated using concentration 
measurements. The weight of PCL MPs and added content of TE-HCL were calculated 
based on flow rate and collection time. 
The LC (loading capacity) of TE-HCL in PCL MPs was calculated using Eq. (1): 
 LC % = %&'()*	,-	&./012340*&5	6789:;%&'()*	,-	<:;	=<2 ×100	%  (1) 
 The EE (encapsulation efficiency) of TE-HCL in PCL MPs was calculated by Eq. 
(2): 
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EE % = %&'()*	,-	&./012340*&5	6789:;%&'()*	,-	'.'*'04	055&5	6789:; ×100	%  (2) 
 
2.8. Anti-bacterial activity test 
The inhibition zone for each membrane sample was measured to determine its anti-
bacterial properties using the agar diffusion method 48. E. coli was used as 
representative Gram-negative (G-) bacteria while S. aureus was selected as model 
Gram-positive (G+) bacteria. Prior to plating bacteria, 20 mL of Violet Red Bile Agar 
and Baird-Parker Agar was poured into sterile petri dishes, respectively. After 
solidification, 200 µL E. coli suspension was spread on to Violet Red Bile Agar plates 
while 200 µL of S. aureus suspension was spread on to Baird-Parker Agar plates. 
Selected fabricated membranes (as 4 mm diameter discs) were placed on both plates. 
The plates were incubated at 37 °C for 24 h. The bacterial inhibition zone of each 
sample was measured 20 times using ImageJ software and data is presented as the mean 
diameter of the disc inhibition zone. 
 
3. Results and Discussion 
3.1. Fabrication of hybrid membranes (HMs) 
For the ES process, TPU solution was stretched into a narrow and stable Taylor 
cone at the tip of the nozzle arising due to an inter-balance between electrical stresses 
and liquid surface tension 49, which subsequently led to the formation of TPU fibers. 
Furthermore, through the use of a rotating collector system, such as a rotating drum or 
a disc, the acquisitions of further stretched and highly oriented fibers have been reported 
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50-52. Compared to a rotating disc, fibers can be prepared in larger quantities when using 
a drum because of a larger deposition area, which therefore improves efficiency in 
production rate and also spatial control. With the aid of the collector, two rotation 
speeds (200 and 3200 rpm) as well as two forming methods (ES and ESy), TPU FMs 
with three different structural designs were prepared by alternating fiber deposition 
angle (at 90°). 
The ESy process (to yield PCL MPs) was identical to ES in terms of the applied 
apparatus and method, although differences in product structure arise due to medium 
properties such as a polymer concentration and chain behavior in solution. Prior to 
collecting PCL MPs on TPU FMs, a sample of MPs were deposited on to microscopic 
glass slides for OM. By combining ES and ESy techniques via side-by-side 
arrangement, three types of HMs were prepared. Fabrication proceeded by patterning 
of TPU FMs with designated alignment after which membranes were laden with PCL 
MPs hosting TE-HCL via ESy, as shown in Figure 1. 
 
3.2. Morphology of synthesized particles and fibers 
Row 1 (Figure 2a, d, g, j, m, p and s) shows schematic diagrams of PCL MPs, 
TPU FMs [(R), (P) and (V)] and HMs [(R), (P) and (V)]. Corresponding rows 2 (Figure 
2b, e, h, k, n, q and t) and 3 (Figure 2c, f, i, l, o, r and u) show optical and scanning 
electron micrographs, respectively. 
PCL MPs are near-uniform and spherical (as shown in Figure 2b and c) possessing 
a mean diameter of 5.1 ± 0.2 µm. Product uniformity proved the process to be suitable 
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for mass and stable particle production which is important for industrial applications. 
Previous studies have shown that spherical PCL particles are ideal for sustained and 
controlled drug release 44,53. 
TPU fiber alignment was varied from random to ordered as shown in Figure 2d-l. 
In the first instance, the rotating drum was used to collect TPU fibers at different 
rotating speeds (from 200 to 3200 rpm) and study its impact on fiber deposition. At 
relatively low speeds (< 200 rpm), fibers appear randomly orientated (Figure 2d, e and 
f) with no regular arrangement. Increasing the rotation speed is conducive to fiber 
orientation control. The ratio of well aligned fibers increases as the rotation speed is 
increased and appeared most ordered at the highest rotation speed of 3200 rpm (Figure 
2g, h and i). during this process, the right compromise between rotation speed and 
evaporation rate of solvent is crucial for the formation of highly oriented fibers 54. When 
the collector rotation speed << fiber deposition speed, fibers appeared randomly 
overlapped and solvent evaporation is hindered. When the rotation speed is >> fiber 
deposition speed; continuous fiber collection is difficult due to breakage caused by finer 
stretched fibers. Therefore, using the rotation speed as a controlled deposition parameter, 
random and parallel TPU fibers were prepared. Post 4 h’ collection, TPU FMs (R) and 
TPU FMs (P) were collected for assessment. Vertical TPU fibers were prepared by 
repositioning parallel fibers (90°) thrice (Figure 2j). Figure 2k and l show optical and 
electron micrographs of TPU fibers deposited in grid patterns, respectively. Whilst each 
deposition step was 1 h, FMs (V) were prepared with four layers at a stack angle of 90°. 
Diameters of TPU fibers in FMs (R), (P) and (V) were 1.21 ± 0.22, 1.06 ± 0.16 and 
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1.02 ± 0.21 µm, respectively. The results show that there was no significant difference 
in the fiber diameter between FMs (P) and (V) due to deployment of identical 
parameters. However, fiber stretching due to accelerated rotation speeds, leads to 
reduced diameters and greater uniformity compared to FMs (R). 
Once optimized, TPU FMs were transferred to the adjacent ESy nozzle for PCL 
MPs deposition. Each membrane type was deposited with MPs for 3 h leading to the 
formation of HMs (R) (Figure 2n), HMs (P) (Figure 2q) and HMs (V) (Figure 2t). 
 
3.3. Water contact angle measurements 
Water contact angle measurements elucidate the hydrophobic/hydrophilic nature of 
a materials surface. The results of water contact angle on three FMs and corresponding 
HMs are shown in Figure 3. The surfaces for all TPU samples indicate FMs are 
hydrophobic. The mean water contact angle on TPU FMs (R) is 116.93 ± 0.49°, which 
was the most pronounced among all samples. TPU FMs (P) and (V) exhibit water 
contact angles of 114.92 ± 0.29° and 110.14 ± 0.73°, respectively. 
The hydrophobicity of membrane surface is largely driven by material composition. 
TPUs comprise segmented polymeric chains composed of hard and soft blocks, and the 
ratio between hard and soft block determines interfacing properties 55. When 
hydrophobic hard segments play a more dominant role than hydrophilic soft segments, 
water contact angles are more likely to be greater than 90° 56. In addition, fiber 
alignment also impacts surface hydrophilicity. Compared to TPU FMs (R), the slight 
increase in surface hydrophilicity is due to an increase in voids for TPU FMs (P) and 
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(V) 54,55 thus contributing to larger pore volume in FMs.  
PCL MP deposition modifies the hydrophobicity of TPU FMs. The results indicate 
surfaces incorporating PCL MPs are hydrophilic, with TPU FMs (R), (P) and (V) 
possessing water contact angles of 78.15 ± 3.15°, 61.56 ± 6.37° and 67.14 ± 2.98°, 
respectively. The clear difference in hydrophilic nature arises due to factors relating TE-
HCL-loaded PCL MPs. Although PCL is hydrophobic, PCL MP deposition 
significantly increases surface roughness of membranes which is known to impact 
water contact angle 48. Hence, the hydrophilic nature of HMs provides an opportunity 
to absorb exudate and thus keep the wound site clean. In addition, the reverse side of 
HMs remain hydrophobic; providing waterproofing and barrier properties. 
 
3.4. Tensile test 
Mechanical properties of HMs were evaluated using tensile testing. Test results for 
three selected samples characterized by stress-strain curves, are shown in Figure 4. 
Among these samples, HMs (P) displayed the greatest tensile strength (32.1 ± 4.9 MPa). 
As the alignment of TPU fibers decreases, the tensile strength of HMs (V) and (R) 
declines; exhibiting tensile strength values of 12.2 ± 2.1 and 11.6 ± 1.6 MPa, 
respectively. However, tensile strain was seen to increase as the alignment decreased. 
The tensile strain for HMs (P) was the lowest (104.2 ± 6.0 %) with HMs (R) displaying 
the greatest strain value (225.6 ± 7.3 %). 
Tensile properties of HMs are affected by fiber microstructure, individual fiber 
properties and geometrical arrangement 54. The three FMs have a near identical 
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microstructure based on the TPU polymer. Fiber diameter has an appreciable influence 
on tensile properties of individual fibers. Three geometrical arrangements are shown in 
Figure 2. The tensile strength decreases with increasing fiber diameter 57,58. Also, well 
aligned fibers display greater tensile strength when compared to their randomly 
arranged counterparts 59. 
For HMs (R), random fiber arrangement, with fibers possessing large diameters, 
ensures interconnection and multi-directional integration; not favoring tensile strain 
enhancement for a specific direction. For this reason, HM (R) membranes displayed the 
greatest tensile strain as well as the lowest tensile strength. Tensile strength was 
simplified equivalent to the product of fiber numbers and the average strength vector 
along the tensile direction of a single fiber, which led to the lowest tensile strength 
among three HMs. 
For HMs (P), fibers are parallel (adjacent) and the tensile direction is along the 
fiber axis. Compared to HMs (R), greater fiber alignment enables HMs (P) to display 
the highest tensile strength although accompanied by reduced elasticity. In this regard, 
elastic HMs (P) with high tensile strength indicate the materials suitability as a medical 
membrane material. In addition, the stress-strain curve for HMs (V) show two tensile 
values. This phenomenon arises because of deposited fiber arrangement. During local 
plastic deformation stage, when the external force exceeds strength limit, the first layer 
shrinks, leading to a decrease in strength until breakage. The remaining three layers 
consolidate the strengthening stage which leads to a secondary local plastic deformation 
stage, and the sample totally breaks at the second fracture point. 
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3.5. FTIR analysis 
Figure 5 shows the FTIR spectra of pure PCL particles, pure TE-HCL powder, TE-
HCL-loaded PCL MPs, TPU FMs and HMs, focusing in the 3500 to 500 cm-1. For PCL, 
characteristic peaks at 1734 cm-1, 2950 cm-1 and 2863 cm-1 indicate C=O stretching, 
CH2 asymmetric stretching and symmetric stretching, respectively 60. For TE-HCL, the 
main peak at 1675 cm-1 shows the presence of C=O 61. For TPU, the peak at 1521 cm-1 
represents amide II 56. Compared to PCL, a new peak at 1676 cm-1 is observed which 
belongs to TE-HCL for TE-HCL-loaded PCL MPs. All aforementioned characteristic 
peaks appear in TE-HCL/PCL/TPU, which confirms HMs were prepared successfully 
without any interactions between various components. 
 
3.6. In vitro drug release 
LC and EE of TE-HCL in PCL MPs was 5.78 % and 86.72 %, respectively. In vitro 
drug release profiles are shown in Figure 6. A variation in TE-HCL release from three 
HMs was observed. HMs (R) samples exhibit fastest cumulative drug release while 
HMs (P) samples display the most sustained release. However, compared to HMs (P) 
and (V); HMs (R) samples display a rapid initial release phase (0-2 h). For example, 
after 1 h, the cumulative release ratios of TE-HCL from HMs (R), (V) and (P) were 
67.52 %, 43.42 % and 38.74 %, respectively. The drug release process includes two 
main steps; particle detachment from membranes and drug diffusion from MPs.  
An important factor contributing towards release rate relates to pore or void 
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properties for each sample, which vary due to geometrical fiber arrangement. TPU FMs 
(R) were prepared by collecting fibers randomly and have minimum voidage because 
of dense deposition in multiple directions, as shown in Figure 2o. According to 
previous studies 62 particles merging with other particles exhibits greater release rates. 
With dense randomly distributed fibers, voids are reduced and particle merging is 
favored. However, for TPU FMs (V) maximum void volume can be expected because 
of the well-placed stacked structure, as shown in Figure 2u. Here, drug-loaded particles 
are able to deposit directly into pores and onto struts. Void volume for TPU FMs (P) is 
between the previously described (two) sample types. Here, most particles are 
embedded in crevices between parallel fibers, resulting in an increase in particle-
membrane forming. Consequently, HMs (P) display the most sustained release rate. In 
conclusion, in vitro drug release tests show geometrical arrangement of membrane 
contributing fibers has a great impact on drug release performance. 
 
3.7. Anti-bacterial test 
Wound healing management involves the prevention or treatment of bacterial 
infections 5. TE-HCL was selected as a model drug based on the broad spectrum anti-
bacterial ability 63,64. The agar diffusion method was used to evaluate anti-bacterial 
properties of HMs over a 24 h test period. E. coli and S. aureus were used as model 
Gram-negative (G-) and Gram-positive (G+) bacteria, respectively. The inhibition zone 
of each sample is shown in Figure 7a and corresponding measurements are shown in 
Figure 7b. 
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Figure 7a (I) and (VI) show Violet Red Bile agar and Baird-Parker agar plates 
without bacteria, respectively. After E. coli and S. aureus suspensions were spread on 
to corresponding plates and incubated for 24 h; color change on both plates was evident, 
as shown in Figure 7a (II) and (VII). Three types of HMs discs (diameter~4 mm) were 
used for bacterial assessment. Figure 7a (III) to (V) show inhibition zones arising from 
HMs (R), (P) and (V) discs against E. coli exhibiting diameters of 18.28 ± 0.16 mm, 
18.23 ± 0.03 mm, 17.05 ± 0.24 mm, respectively. Figure 7a (VIII) to (X) show 
inhibition zones against S. aureus displaying inhibition zones of 18.26 ± 0.14 mm, 
18.10 ± 0.14 mm, 18.18 ± 0.14 mm, respectively. The results indicate matrices are ideal 
to prevent bacterial activity when compared to control groups (Figure 7a (II) and (VII)). 
Inhibition zones displayed slightly improved activity at the 24 h point. The results 
indicate matrices are well suited to prevent bacterial activity when compared to control 
groups (Figure 7a (II) and (VII)). In addition, an insignificant difference between 
inhibition zones in three experimental groups shows that fiber direction does not impact 
E. coli and S. aureus inhibition. This further confirms drug release from TE-HCL loaded 
PCL particles has a great impact on anti-bacterial performance. 
 
4. Conclusion 
Medical bandages are vital to wound healing and repair. Thus, developing a facile 
method to fabricate bandages with tailored strength, anti-bacterial and managed drug 
release properties becomes imperative. In our work, PCL MP modified TPU FMs with 
three different fibrous patterns (R, P and V) were fabricated combining ES with ESy 
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techniques. TE-HCL was loaded in PCL MPs as a model drug, and TPU FMs patterning 
was regulated using a rotating collector. OM, SEM and FTIR analyses indicate three 
patterns were successfully prepared. Water contact angle tests show HMs possess a 
hydrophobic outer layer and hydrophilic inner layer; providing waterproofing and 
wound exudate absorption properties, respectively. Tensile tests show HMs (P) have 
high tensile strength with elasticity. In vitro drug release tests also demonstrate HMs (P) 
have sustained-release properties. Anti-bacterial tests indicate all three HMs have 
outstanding anti-bacterial activity against E. coli and S. aureus. In summary, HMs (P) 
are the best candidate for skin wound care applications. Compared to other drug loaded 
membranes as potential skin products, the current system displays multiple functions 
with tailorable aspects, which can be prepared in rapid fashion. 
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Table 1. HMs Composition. 
Item Name Description 
HMs (R) PCL MPs-TPU FMs (R) 
HMs (P) PCL MPs-TPU FMs (P) 
HMs (V) PCL MPs-TPU FMs (V) 
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Figure 1. Schematic diagram showing hybrid membrane engineering using ESy and 
ES techniques via side-by-side approach. 
 
 
 
Figure 2. Diagrammatic images, optical and scanning electron micrographs of: (a), (b) 
and (c) showing PCL MPs. (d), (e) and (f) showing TPU FMs (R). (g), (h) and (i) 
showing TPU FMs (P). (j), (k) and (l) showing TPU FMs (V). (m), (n) and (o) showing 
HMs (R). (p), (q) and (r) showing HMs (P). (s), (t) and (u) showing HMs (V). 
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Figure 3. Water contact angles on TPU FMs (R) and HMs (R); TPU FMs (P) and HMs 
(P); TPU FMs (V) and HMs (V). 
 
 
Figure 4. Stress-strain curves of HMs (R), HMs (P) and HMs (V) samples. 
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Figure 5. FTIR spectra of HMs, TPU FMs, TE-HCL-loaded PCL MPs, pure TE-HCL 
powder, pure PCL beads. 
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Figure 6. Drug release from HMs (R), HMs (P) and HMs (V) samples. 
 
 
Figure 7. (a) Violet Red Bile agar plates: (I) Blank, (II) E. coli, (III) E. coli with HMs 
(R) disc, (IV) E. coli with HMs (P) disc and (V) E. coli with HMs (V) disc. Baird-
Parker agar plates: (VI) Blank, (VII) S. aureus, (VIII) S. aureus with HMs (R) disc, (IX) 
S. aureus with HMs (P) disc and (X) S. aureus with HMs (V) disc. (b) Diameter of 
inhibition zones of three HMs. 
28 
 
Text for ToC 
Particulate laden fibrous membranes are prepared using both electrospinning and 
electrospraying techniques. A rotating collector is used to realize random and ordered 
fibrous membrane patterns which then display great differences in mechanical and drug 
release properties. 
 
Figure for ToC_ 
 
